Skip to main content

Tonix Pharmaceuticals Holding Corp.

TNXP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001430306

In the last 90 days, Tonix Pharmaceuticals Holding Corp. insiders filed 2 open-market purchases and 0 sales; 102 institutions reported holding it in 13F filings for Q2 2026, worth $119.4M in total; no superinvestor holds it.

Q3 2023 vs. Q2 2023

How the institutions holding Tonix Pharmaceuticals Holding Corp. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023All holders in Q2 2023

13F holders of TNXP: Q2 2023 compared with Q3 2023
MeasureQ2 2023Q3 2023Change
Holders3132+1
Shares1.02M3.69M+2.67M (+261.0%)
Value$1.62M$2.01M+$397.1K (+24.6%)

New holders (7)

Institutions that held Tonix Pharmaceuticals Holding Corp. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to TNXP in Q3 2023
InstitutionSharesValue% of portfolio
Armistice Capital, LLC1,450,000$790.3K0.02%
Sabby Management, LLC1,247,465$679.9K2.15%
Virtu Financial LLC66,989$37.0K0.00%
Millennium Management LLC18,724$10.2K0.00%
FMR LLC6$30.00%
Qube Research & Technologies Ltd4$20.00%
Royal Bank of Canada267$00.00%

Sold out (6)

Institutions that held Tonix Pharmaceuticals Holding Corp. at the end of Q2 2023 and filed for Q3 2023 without it.

Institutions that sold out of TNXP in Q3 2023
InstitutionShares, Q2 2023Value, Q2 2023
Raymond James & Associates44,364$70.1K
Two Sigma Securities, LLC24,786$39.2K
Two Sigma Investments, LP12,750$20.1K
The PNC Financial Services Group, Inc.161$254
Citigroup Inc15$24
Lindbrook Capital, LLC7$11